SNP | Group (n) | Minor Allele Frequency, % | Genotype Frequency, n (%) | OR (95% CI) | p | Corrected p | ||
---|---|---|---|---|---|---|---|---|
−238 G/A | GG | GA | AA | |||||
Control (362) | 4.1 | 332 (91.2) | 30 (8.3) | 0 (0) | 1.72 (0.83–3.56) | 0.15 | 0.75 | |
Patient (110) | 6.4 | 97 (88.2) | 12 (10.9) | 1 (0.9) | ||||
−308 G/A | GG | GA | AA | |||||
Control (362) | 4.7 | 330 (91.2) | 30 (8.3) | 2 (0.6) | 0.64 (0.25–1.60) | 0.37 | 1.85 | |
Patient (110) | 2.7 | 104 (94.5) | 6 (5.5) | 0 (0) | ||||
−857 C/T | CC | CT | TT | |||||
Control (362) | 11.6 | 286 (79.0) | 68 (18.8) | 8 (2.2) | 1.14 (0.66–1.99) | 0.62 | 3.1 | |
Patient (110) | 10.0 | 88 (80.0) | 22 (20.0) | 0 (0) | ||||
−863 C/A | CC | CA | AA | |||||
Control (362) | 25.7 | 202 (55.8) | 134 (37.0) | 26 (7.2) | 0.54 (0.34–0.87) | 0.011 | 0.055 | |
Patient (110) | 18.2 | 76 (69.1) | 28 (25.5) | 6 (5.4) | ||||
−1031 T/C | TT | TC | CC | |||||
Control (362) | 24.9 | 200 (55.2) | 144 (39.8) | 18 (5.0) | 0.90 (0.58–1.41) | 0.65 | 3.25 | |
Patient (110) | 24.5 | 64 (58.2) | 38 (34.5) | 8 (7.3) |
SNP: single-nucleotide polymorphism.